AMY RAPP: Open Payments
NPI 1184726580 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 24 payments from 13 companies in 2025. Trend: 2023 $429 · 2024 $448 · 2025 $540
Food & beverage: $540
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $114 |
| Neurocrine BioSciences, Inc. | 5 | $106 |
| UCB, Inc. | 3 | $61 |
| Stryker Corporation | 1 | $53 |
| ACADIA Pharmaceuticals Inc | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| JAZZ PHARMACEUTICALS INC. | 1 | $26 |
| Amgen Inc. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $19 |
| Heron Therapeutics, Inc. | 1 | $18 |
Products named: INGREZZA, QULIPTA, Briviact, N/A, NUPLAZID, UBRELVY, HYQVIA, XYWAV.
Industry payments across AL — which companies pay providers there.
